Loading...
XJPX4041
Market cap981mUSD
Jan 20, Last price  
2,830.00JPY
1D
1.65%
1Q
13.75%
Jan 2017
106.19%
Name

Nippon Soda Co Ltd

Chart & Performance

D1W1MN
XJPX:4041 chart
P/E
9.38
P/S
1.01
EPS
301.60
Div Yield, %
12.93%
Shrs. gr., 5y
-1.62%
Rev. gr., 5y
1.18%
Revenues
154.43b
-10.64%
143,934,000,000145,300,000,000157,561,000,000151,021,000,000132,486,000,000123,238,000,000121,118,000,000127,581,000,000140,649,000,000148,062,000,000142,711,000,000128,647,000,000141,230,000,000145,663,000,000144,739,000,000139,363,000,000152,536,000,000172,811,000,000154,429,000,000
Net income
16.61b
-0.48%
-6,263,000,0003,426,000,0005,155,000,0006,751,000,0008,571,000,0005,548,000,0007,044,000,0005,303,000,0005,833,000,00010,945,000,00014,313,000,0008,785,000,0006,378,000,0005,802,000,0006,759,000,0007,360,000,00012,683,000,00016,692,000,00016,612,000,000
CFO
5.73b
-63.25%
14,157,000,0009,627,000,00015,737,000,00014,584,000,00013,044,000,00013,425,000,0009,867,000,0009,836,000,00011,260,000,0009,588,000,00010,639,000,00041,236,000,00012,085,000,00011,677,000,00012,449,000,00013,821,000,00014,545,000,00015,590,000,0005,729,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 13, 2025

Profile

Nippon Soda Co., Ltd. develops, produces, processes, imports, markets, sells, and exports chemicals, agrochemicals, and other products in Japan and internationally. The company offers agrochemicals, including fungicides, insecticides, acaricides, and herbicides. It also provides specialty chemicals organic, such as titanate; magnesium ethylate, o-tolidine diisocyanate, adhesive agents for film lamination, photoresist base resins, developers for thermal paper, epoxy catalyst, permethyl polysilane, crown ethers, photocatalysts, bactericides, algaecides, fungicides for wood, insecticides, and termiticide, as well as liquid-1, 2-polybutadiene. In addition, the company offers pharmaceutical excipients, including diaminomaleonitrile, sodium stearyl fumarate, and hydroxypropyl cellulose; and eco business and consumer chemicals, such as inorganic chlorine tablets and granules, toilet-use uroliths removers, and chelating agents for heavy metal, as well as treatment systems by for PCBs. Further, it provides chlor-alkali chemicals comprising caustic soda, hydrochloric acid, liquid chlorine, potassium cyanide, sodium hypochlorite, sodium metal, sodium alcoholates, sodium cyanide, phosphorus oxychloride, and phosphorus trichloride. Additionally, the company offers functional products, synthetic resins and other plastic materials, dyes, industrial devices, and construction products; pharmaceuticals; synthetic resin molded products; smoking, deoxygenating, and dehumidifying agents; industrial chemicals; household goods; agricultural materials and other products; and feed additives. It also engages in warehousing, packaging, customs brokerage, and insurance agency business, as well as leasing activities; freight forwarding, truck transportation; plant construction and civil engineering activities; mining of soil and rocks; and manufacture and sale of non-ferrous metals and concrete products. Nippon Soda Co., Ltd. was incorporated in 1920 and is headquartered in Tokyo, Japan.
IPO date
May 16, 1949
Employees
2,418
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
154,429,000
-10.64%
172,811,000
13.29%
152,536,000
9.45%
Cost of revenue
139,347,000
154,338,000
139,154,000
Unusual Expense (Income)
NOPBT
15,082,000
18,473,000
13,382,000
NOPBT Margin
9.77%
10.69%
8.77%
Operating Taxes
4,634,000
7,293,000
4,438,000
Tax Rate
30.73%
39.48%
33.16%
NOPAT
10,448,000
11,180,000
8,944,000
Net income
16,612,000
-0.48%
16,692,000
31.61%
12,683,000
72.32%
Dividends
(7,505,000)
(5,979,000)
(3,504,000)
Dividend yield
8.91%
9.29%
7.45%
Proceeds from repurchase of equity
(2,007,000)
3,890,000
1,035,000
BB yield
2.38%
-6.05%
-2.20%
Debt
Debt current
23,795,000
15,395,000
22,572,000
Long-term debt
25,182,000
16,960,000
17,335,000
Deferred revenue
2,781,000
2,695,000
Other long-term liabilities
4,598,000
2,790,000
3,976,000
Net debt
(43,409,000)
(54,642,000)
(39,130,000)
Cash flow
Cash from operating activities
5,729,000
15,590,000
14,545,000
CAPEX
(11,420,000)
(12,589,000)
(11,988,000)
Cash from investing activities
(9,594,000)
(4,863,000)
(11,620,000)
Cash from financing activities
6,694,000
(10,441,000)
(4,802,000)
FCF
(6,489,000)
11,796,000
1,813,000
Balance
Cash
22,215,000
18,506,000
17,936,000
Long term investments
70,171,000
68,491,000
61,101,000
Excess cash
84,664,550
78,356,450
71,410,200
Stockholders' equity
167,869,000
307,213,000
283,861,000
Invested Capital
158,318,450
126,144,550
130,294,800
ROIC
7.35%
8.72%
7.01%
ROCE
5.94%
8.73%
6.41%
EV
Common stock shares outstanding
27,806
27,877
27,913
Price
3,030.00
31.31%
2,307.50
36.94%
1,685.00
-3.58%
Market cap
84,252,180
30.98%
64,326,178
36.77%
47,033,405
-6.70%
EV
42,268,180
171,066,178
158,661,405
EBITDA
22,954,000
27,581,000
21,989,000
EV/EBITDA
1.84
6.20
7.22
Interest
281,000
297,000
279,000
Interest/NOPBT
1.86%
1.61%
2.08%